Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 6Unknown 3Recruiting 2Not yet recruiting 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Myofibroma 1Menorrhagia 1Leiomyoma 1Dysmenorrhea 1Blood Loss, Surgical 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × Uterine Myomectomy × Clear all
NCT06692335 2026-03-27

HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids

Chinese University of Hong Kong

Phase NA Recruiting
112 enrolled

Dysmenorrhea, Leiomyoma, Menorrhagia

NCT06882824 2025-09-24

HEMOMYOC

University Hospital, Clermont-Ferrand

Phase NA Recruiting
80 enrolled

Blood Loss, Surgical, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡